Assessing the Variations in Breast/Ovarian Cancer Risk for Chinese BRCA1/2 Carriers.

Ang Li,Shuai Hao,Jiaqi Luo,Yi Zi,Zhaoji Lan,Tianliangwen Zhou,Qihuan Zhi,Jiamin Zhan,Gang Sun,Yujian Shi,Donglin Luo

Journal of oncology（2022）

引用 2|浏览7

暂无评分

摘要

carriers with different genotypes have significantly different cancer risks. An optimal risk assessment should be mutation specific, rather than concerning a single figure.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要